VITEK, A.; CETKOVSKY, P.; DOBROVOLNA, M.; IVASKOVA, E.; KORINKOVA, P.; KOVAROVA, P.; KUPKOVA, L.; LOUDOVA, M.; MARKOVA, M.; MATEJKOVA, E.; NAVRATILOVA, J.; PITTROVA, H.; POHLREICH, D.; SAJDOVA, J.; SPONEROVA, D.; VALKOVA, V.; VRANA, M.; VYTISKOVA, J. ATG (Fresenius) 20 mg/kg b.w. + CSA is sufficent GvHD prophylactic regimen for fully matched related and unrelated HSCT, while 40 mg/kg b.w. of ATG + CSA and MMF should be used for partially matched HSCT : a single-centre experience. Bone marrow transplantation. 2007, vol. 39, no. S1, s. S114. ISSN 0268-3369.
Ústav hematologie a krevní transfúze Praha